Chardan Reiterates Sell On Esperion Therapeutics, Sees At Least 6 Reasons To Beware
July 08, 2015 at 08:57 AM EDT
In a report published Wednesday, Chardan Capital Markets analyst Gbola Amusa maintained a Sell rating on Esperion Therapeutics Inc ...